Exane Derivatives’s Avalara, Inc. AVLR Stock Holding History

Exane Derivatives’s Portfolio AVLR Stock Details AVLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$49.3K	Hold	699	–	–	0.03%	314
2022 Q1	$69.6K	Buy	+699	New	+$70.9K	0.02%	522
2021 Q4	–	Sell	-475	Closed	-$83K	–	1112
2021 Q3	$83K	Buy	475 +48	+11%	+$8.25K	0.02%	551
2021 Q2	$67K	Buy	427 +410	+2,412%	+$57.1K	0.02%	598
2021 Q1	$2.27K	Buy	17 +6	+55%	+$925	﹤0.01%	670
2020 Q4	$1.81K	Buy	+11	New	+$1.76K	﹤0.01%	634

Other funds holding AVLR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Exane Derivatives's AVLR Position: Q2 2022 in Review

Exane Derivatives held its Avalara, Inc. (AVLR) position steady in Q2 2022 at 699 shares worth $49.3K. The position accounts for 0.03% of the portfolio, ranked #314.

Exane Derivatives first reported a position in AVLR in Q4 2020 and has held it in 6 quarters since. The position peaked at $83K in Q3 2021. 392 funds tracked by Wall St. Rank hold AVLR as of Q2 2022.

Exane Derivatives held 699 shares of Avalara, Inc. worth $49.3K as of Q2 2022.
Exane Derivatives left its Avalara, Inc. share count unchanged in Q2 2022.
Avalara, Inc. made up 0.03% of Exane Derivatives's portfolio in Q2 2022, its #314 holding.
Exane Derivatives first reported a position in Avalara, Inc. in Q4 2020 and has held it in 6 quarters since.
Exane Derivatives's Avalara, Inc. position peaked at $83K in Q3 2021.
392 funds tracked by Wall St. Rank held Avalara, Inc. as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.